What has FDA approval for Exondys 51 meant for DMD patients?
It has been deemed one of the most controversial drug approvals in recent history, but when the FDA approved Sarepta Therapeutics’ Exondys 51, on the 19th of September, 2016, Duchenne muscular dystrophy (DMD) patients, their [...]